Medical Care

Global Parkinson’s Disease Treatment Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for Parkinson’s Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parkinson’s Disease Treatment.
The Parkinson’s Disease Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Parkinson’s Disease Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Parkinson’s Disease Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva
Roche
Prothena
Acorda Therapeutics
Voyager Therapeutics
Impax Pharmaceuticals
UCB
AbbVie
MSD
Orion Pharmaceuticals
Intec Pharma
NeuroDerm
Adamas Therapeutics
Acadia
Sunovion
GSK
Segment by Type
Oral
Transdermal
Subcutaneous
Intestinal Infusion
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Parkinson’s Disease Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parkinson’s Disease Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral
1.2.3 Transdermal
1.2.4 Subcutaneous
1.2.5 Intestinal Infusion
1.3 Market by Application
1.3.1 Global Parkinson’s Disease Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Parkinson’s Disease Treatment Market Perspective (2020-2031)
2.2 Global Parkinson’s Disease Treatment Growth Trends by Region
2.2.1 Global Parkinson’s Disease Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Parkinson’s Disease Treatment Historic Market Size by Region (2020-2025)
2.2.3 Parkinson’s Disease Treatment Forecasted Market Size by Region (2026-2031)
2.3 Parkinson’s Disease Treatment Market Dynamics
2.3.1 Parkinson’s Disease Treatment Industry Trends
2.3.2 Parkinson’s Disease Treatment Market Drivers
2.3.3 Parkinson’s Disease Treatment Market Challenges
2.3.4 Parkinson’s Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Parkinson’s Disease Treatment Players by Revenue
3.1.1 Global Top Parkinson’s Disease Treatment Players by Revenue (2020-2025)
3.1.2 Global Parkinson’s Disease Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Parkinson’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Parkinson’s Disease Treatment Revenue
3.4 Global Parkinson’s Disease Treatment Market Concentration Ratio
3.4.1 Global Parkinson’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parkinson’s Disease Treatment Revenue in 2024
3.5 Global Key Players of Parkinson’s Disease Treatment Head office and Area Served
3.6 Global Key Players of Parkinson’s Disease Treatment, Product and Application
3.7 Global Key Players of Parkinson’s Disease Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Parkinson’s Disease Treatment Breakdown Data by Type
4.1 Global Parkinson’s Disease Treatment Historic Market Size by Type (2020-2025)
4.2 Global Parkinson’s Disease Treatment Forecasted Market Size by Type (2026-2031)
5 Parkinson’s Disease Treatment Breakdown Data by Application
5.1 Global Parkinson’s Disease Treatment Historic Market Size by Application (2020-2025)
5.2 Global Parkinson’s Disease Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Parkinson’s Disease Treatment Market Size (2020-2031)
6.2 North America Parkinson’s Disease Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Parkinson’s Disease Treatment Market Size by Country (2020-2025)
6.4 North America Parkinson’s Disease Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Parkinson’s Disease Treatment Market Size (2020-2031)
7.2 Europe Parkinson’s Disease Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Parkinson’s Disease Treatment Market Size by Country (2020-2025)
7.4 Europe Parkinson’s Disease Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Parkinson’s Disease Treatment Market Size (2020-2031)
8.2 Asia-Pacific Parkinson’s Disease Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Parkinson’s Disease Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Parkinson’s Disease Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Parkinson’s Disease Treatment Market Size (2020-2031)
9.2 Latin America Parkinson’s Disease Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Parkinson’s Disease Treatment Market Size by Country (2020-2025)
9.4 Latin America Parkinson’s Disease Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Parkinson’s Disease Treatment Market Size (2020-2031)
10.2 Middle East & Africa Parkinson’s Disease Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Parkinson’s Disease Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Parkinson’s Disease Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Teva Business Overview
11.1.3 Teva Parkinson’s Disease Treatment Introduction
11.1.4 Teva Revenue in Parkinson’s Disease Treatment Business (2020-2025)
11.1.5 Teva Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Parkinson’s Disease Treatment Introduction
11.2.4 Roche Revenue in Parkinson’s Disease Treatment Business (2020-2025)
11.2.5 Roche Recent Development
11.3 Prothena
11.3.1 Prothena Company Details
11.3.2 Prothena Business Overview
11.3.3 Prothena Parkinson’s Disease Treatment Introduction
11.3.4 Prothena Revenue in Parkinson’s Disease Treatment Business (2020-2025)
11.3.5 Prothena Recent Development
11.4 Acorda Therapeutics
11.4.1 Acorda Therapeutics Company Details
11.4.2 Acorda Therapeutics Business Overview
11.4.3 Acorda Therapeutics Parkinson’s Disease Treatment Introduction
11.4.4 Acorda Therapeutics Revenue in Parkinson’s Disease Treatment Business (2020-2025)
11.4.5 Acorda Therapeutics Recent Development
11.5 Voyager Therapeutics
11.5.1 Voyager Therapeutics Company Details
11.5.2 Voyager Therapeutics Business Overview
11.5.3 Voyager Therapeutics Parkinson’s Disease Treatment Introduction
11.5.4 Voyager Therapeutics Revenue in Parkinson’s Disease Treatment Business (2020-2025)
11.5.5 Voyager Therapeutics Recent Development
11.6 Impax Pharmaceuticals
11.6.1 Impax Pharmaceuticals Company Details
11.6.2 Impax Pharmaceuticals Business Overview
11.6.3 Impax Pharmaceuticals Parkinson’s Disease Treatment Introduction
11.6.4 Impax Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business (2020-2025)
11.6.5 Impax Pharmaceuticals Recent Development
11.7 UCB
11.7.1 UCB Company Details
11.7.2 UCB Business Overview
11.7.3 UCB Parkinson’s Disease Treatment Introduction
11.7.4 UCB Revenue in Parkinson’s Disease Treatment Business (2020-2025)
11.7.5 UCB Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Parkinson’s Disease Treatment Introduction
11.8.4 AbbVie Revenue in Parkinson’s Disease Treatment Business (2020-2025)
11.8.5 AbbVie Recent Development
11.9 MSD
11.9.1 MSD Company Details
11.9.2 MSD Business Overview
11.9.3 MSD Parkinson’s Disease Treatment Introduction
11.9.4 MSD Revenue in Parkinson’s Disease Treatment Business (2020-2025)
11.9.5 MSD Recent Development
11.10 Orion Pharmaceuticals
11.10.1 Orion Pharmaceuticals Company Details
11.10.2 Orion Pharmaceuticals Business Overview
11.10.3 Orion Pharmaceuticals Parkinson’s Disease Treatment Introduction
11.10.4 Orion Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business (2020-2025)
11.10.5 Orion Pharmaceuticals Recent Development
11.11 Intec Pharma
11.11.1 Intec Pharma Company Details
11.11.2 Intec Pharma Business Overview
11.11.3 Intec Pharma Parkinson’s Disease Treatment Introduction
11.11.4 Intec Pharma Revenue in Parkinson’s Disease Treatment Business (2020-2025)
11.11.5 Intec Pharma Recent Development
11.12 NeuroDerm
11.12.1 NeuroDerm Company Details
11.12.2 NeuroDerm Business Overview
11.12.3 NeuroDerm Parkinson’s Disease Treatment Introduction
11.12.4 NeuroDerm Revenue in Parkinson’s Disease Treatment Business (2020-2025)
11.12.5 NeuroDerm Recent Development
11.13 Adamas Therapeutics
11.13.1 Adamas Therapeutics Company Details
11.13.2 Adamas Therapeutics Business Overview
11.13.3 Adamas Therapeutics Parkinson’s Disease Treatment Introduction
11.13.4 Adamas Therapeutics Revenue in Parkinson’s Disease Treatment Business (2020-2025)
11.13.5 Adamas Therapeutics Recent Development
11.14 Acadia
11.14.1 Acadia Company Details
11.14.2 Acadia Business Overview
11.14.3 Acadia Parkinson’s Disease Treatment Introduction
11.14.4 Acadia Revenue in Parkinson’s Disease Treatment Business (2020-2025)
11.14.5 Acadia Recent Development
11.15 Sunovion
11.15.1 Sunovion Company Details
11.15.2 Sunovion Business Overview
11.15.3 Sunovion Parkinson’s Disease Treatment Introduction
11.15.4 Sunovion Revenue in Parkinson’s Disease Treatment Business (2020-2025)
11.15.5 Sunovion Recent Development
11.16 GSK
11.16.1 GSK Company Details
11.16.2 GSK Business Overview
11.16.3 GSK Parkinson’s Disease Treatment Introduction
11.16.4 GSK Revenue in Parkinson’s Disease Treatment Business (2020-2025)
11.16.5 GSK Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Parkinson’s Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Oral
Table 3. Key Players of Transdermal
Table 4. Key Players of Subcutaneous
Table 5. Key Players of Intestinal Infusion
Table 6. Global Parkinson’s Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Parkinson’s Disease Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Parkinson’s Disease Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Parkinson’s Disease Treatment Market Share by Region (2020-2025)
Table 10. Global Parkinson’s Disease Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Parkinson’s Disease Treatment Market Share by Region (2026-2031)
Table 12. Parkinson’s Disease Treatment Market Trends
Table 13. Parkinson’s Disease Treatment Market Drivers
Table 14. Parkinson’s Disease Treatment Market Challenges
Table 15. Parkinson’s Disease Treatment Market Restraints
Table 16. Global Parkinson’s Disease Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Parkinson’s Disease Treatment Market Share by Players (2020-2025)
Table 18. Global Top Parkinson’s Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson’s Disease Treatment as of 2024)
Table 19. Ranking of Global Top Parkinson’s Disease Treatment Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Parkinson’s Disease Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Parkinson’s Disease Treatment, Headquarters and Area Served
Table 22. Global Key Players of Parkinson’s Disease Treatment, Product and Application
Table 23. Global Key Players of Parkinson’s Disease Treatment, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Parkinson’s Disease Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Parkinson’s Disease Treatment Revenue Market Share by Type (2020-2025)
Table 27. Global Parkinson’s Disease Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Parkinson’s Disease Treatment Revenue Market Share by Type (2026-2031)
Table 29. Global Parkinson’s Disease Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Parkinson’s Disease Treatment Revenue Market Share by Application (2020-2025)
Table 31. Global Parkinson’s Disease Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Parkinson’s Disease Treatment Revenue Market Share by Application (2026-2031)
Table 33. North America Parkinson’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Parkinson’s Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Parkinson’s Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Parkinson’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Parkinson’s Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Parkinson’s Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Parkinson’s Disease Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Parkinson’s Disease Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Parkinson’s Disease Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Parkinson’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Parkinson’s Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Parkinson’s Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Parkinson’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Parkinson’s Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Parkinson’s Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 48. Teva Company Details
Table 49. Teva Business Overview
Table 50. Teva Parkinson’s Disease Treatment Product
Table 51. Teva Revenue in Parkinson’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 52. Teva Recent Development
Table 53. Roche Company Details
Table 54. Roche Business Overview
Table 55. Roche Parkinson’s Disease Treatment Product
Table 56. Roche Revenue in Parkinson’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 57. Roche Recent Development
Table 58. Prothena Company Details
Table 59. Prothena Business Overview
Table 60. Prothena Parkinson’s Disease Treatment Product
Table 61. Prothena Revenue in Parkinson’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 62. Prothena Recent Development
Table 63. Acorda Therapeutics Company Details
Table 64. Acorda Therapeutics Business Overview
Table 65. Acorda Therapeutics Parkinson’s Disease Treatment Product
Table 66. Acorda Therapeutics Revenue in Parkinson’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 67. Acorda Therapeutics Recent Development
Table 68. Voyager Therapeutics Company Details
Table 69. Voyager Therapeutics Business Overview
Table 70. Voyager Therapeutics Parkinson’s Disease Treatment Product
Table 71. Voyager Therapeutics Revenue in Parkinson’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 72. Voyager Therapeutics Recent Development
Table 73. Impax Pharmaceuticals Company Details
Table 74. Impax Pharmaceuticals Business Overview
Table 75. Impax Pharmaceuticals Parkinson’s Disease Treatment Product
Table 76. Impax Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 77. Impax Pharmaceuticals Recent Development
Table 78. UCB Company Details
Table 79. UCB Business Overview
Table 80. UCB Parkinson’s Disease Treatment Product
Table 81. UCB Revenue in Parkinson’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 82. UCB Recent Development
Table 83. AbbVie Company Details
Table 84. AbbVie Business Overview
Table 85. AbbVie Parkinson’s Disease Treatment Product
Table 86. AbbVie Revenue in Parkinson’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 87. AbbVie Recent Development
Table 88. MSD Company Details
Table 89. MSD Business Overview
Table 90. MSD Parkinson’s Disease Treatment Product
Table 91. MSD Revenue in Parkinson’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 92. MSD Recent Development
Table 93. Orion Pharmaceuticals Company Details
Table 94. Orion Pharmaceuticals Business Overview
Table 95. Orion Pharmaceuticals Parkinson’s Disease Treatment Product
Table 96. Orion Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 97. Orion Pharmaceuticals Recent Development
Table 98. Intec Pharma Company Details
Table 99. Intec Pharma Business Overview
Table 100. Intec Pharma Parkinson’s Disease Treatment Product
Table 101. Intec Pharma Revenue in Parkinson’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 102. Intec Pharma Recent Development
Table 103. NeuroDerm Company Details
Table 104. NeuroDerm Business Overview
Table 105. NeuroDerm Parkinson’s Disease Treatment Product
Table 106. NeuroDerm Revenue in Parkinson’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 107. NeuroDerm Recent Development
Table 108. Adamas Therapeutics Company Details
Table 109. Adamas Therapeutics Business Overview
Table 110. Adamas Therapeutics Parkinson’s Disease Treatment Product
Table 111. Adamas Therapeutics Revenue in Parkinson’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 112. Adamas Therapeutics Recent Development
Table 113. Acadia Company Details
Table 114. Acadia Business Overview
Table 115. Acadia Parkinson’s Disease Treatment Product
Table 116. Acadia Revenue in Parkinson’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 117. Acadia Recent Development
Table 118. Sunovion Company Details
Table 119. Sunovion Business Overview
Table 120. Sunovion Parkinson’s Disease Treatment Product
Table 121. Sunovion Revenue in Parkinson’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 122. Sunovion Recent Development
Table 123. GSK Company Details
Table 124. GSK Business Overview
Table 125. GSK Parkinson’s Disease Treatment Product
Table 126. GSK Revenue in Parkinson’s Disease Treatment Business (2020-2025) & (US$ Million)
Table 127. GSK Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report


List of Figures
Figure 1. Parkinson’s Disease Treatment Picture
Figure 2. Global Parkinson’s Disease Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Parkinson’s Disease Treatment Market Share by Type: 2024 VS 2031
Figure 4. Oral Features
Figure 5. Transdermal Features
Figure 6. Subcutaneous Features
Figure 7. Intestinal Infusion Features
Figure 8. Global Parkinson’s Disease Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Parkinson’s Disease Treatment Market Share by Application: 2024 VS 2031
Figure 10. Hospital Pharmacy Case Studies
Figure 11. Retail Pharmacy Case Studies
Figure 12. Online Pharmacy Case Studies
Figure 13. Parkinson’s Disease Treatment Report Years Considered
Figure 14. Global Parkinson’s Disease Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Parkinson’s Disease Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Parkinson’s Disease Treatment Market Share by Region: 2024 VS 2031
Figure 17. Global Parkinson’s Disease Treatment Market Share by Players in 2024
Figure 18. Global Top Parkinson’s Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson’s Disease Treatment as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Parkinson’s Disease Treatment Revenue in 2024
Figure 20. North America Parkinson’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Parkinson’s Disease Treatment Market Share by Country (2020-2031)
Figure 22. United States Parkinson’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Parkinson’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Parkinson’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Parkinson’s Disease Treatment Market Share by Country (2020-2031)
Figure 26. Germany Parkinson’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Parkinson’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Parkinson’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Parkinson’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Parkinson’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Parkinson’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Parkinson’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Parkinson’s Disease Treatment Market Share by Region (2020-2031)
Figure 34. China Parkinson’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Parkinson’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Parkinson’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Parkinson’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Parkinson’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Parkinson’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Parkinson’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Parkinson’s Disease Treatment Market Share by Country (2020-2031)
Figure 42. Mexico Parkinson’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Parkinson’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Parkinson’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Parkinson’s Disease Treatment Market Share by Country (2020-2031)
Figure 46. Turkey Parkinson’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Parkinson’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Parkinson’s Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Teva Revenue Growth Rate in Parkinson’s Disease Treatment Business (2020-2025)
Figure 50. Roche Revenue Growth Rate in Parkinson’s Disease Treatment Business (2020-2025)
Figure 51. Prothena Revenue Growth Rate in Parkinson’s Disease Treatment Business (2020-2025)
Figure 52. Acorda Therapeutics Revenue Growth Rate in Parkinson’s Disease Treatment Business (2020-2025)
Figure 53. Voyager Therapeutics Revenue Growth Rate in Parkinson’s Disease Treatment Business (2020-2025)
Figure 54. Impax Pharmaceuticals Revenue Growth Rate in Parkinson’s Disease Treatment Business (2020-2025)
Figure 55. UCB Revenue Growth Rate in Parkinson’s Disease Treatment Business (2020-2025)
Figure 56. AbbVie Revenue Growth Rate in Parkinson’s Disease Treatment Business (2020-2025)
Figure 57. MSD Revenue Growth Rate in Parkinson’s Disease Treatment Business (2020-2025)
Figure 58. Orion Pharmaceuticals Revenue Growth Rate in Parkinson’s Disease Treatment Business (2020-2025)
Figure 59. Intec Pharma Revenue Growth Rate in Parkinson’s Disease Treatment Business (2020-2025)
Figure 60. NeuroDerm Revenue Growth Rate in Parkinson’s Disease Treatment Business (2020-2025)
Figure 61. Adamas Therapeutics Revenue Growth Rate in Parkinson’s Disease Treatment Business (2020-2025)
Figure 62. Acadia Revenue Growth Rate in Parkinson’s Disease Treatment Business (2020-2025)
Figure 63. Sunovion Revenue Growth Rate in Parkinson’s Disease Treatment Business (2020-2025)
Figure 64. GSK Revenue Growth Rate in Parkinson’s Disease Treatment Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies